Regulatory affairs/ regulatory requirements for drug approval

Authors

Prajakta R. Patil
Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgaon, Kolhapur, 416 112, India
Sachin S. Mali
Department of Pharmaceutics, Bharati Vidyapeeth college of Pharmacy, Kolhapur 416 013, India
Riya R. Patil
Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgaon, Kolhapur, 416 112, India
Dhanashree R. Davare
Department of Pharmaceutics, Ashokrao Mane College of Pharmacy, Peth-Vadgaon, Kolhapur, 416 112, India

Synopsis

Introduction, Regulatory Affairs Historical Overview, Regulatory Authorities, Regulatory Affairs Department Role, and Regulatory Affairs Professionals' Responsibilities. Regulations needed to approve a drug: Clinical research / BE studies, Clinical Research Protocols, Biostatistics in Pharmaceutical Product Development, Data Presentation for FDA Submissions, Pharmacology, Drug Metabolism and Toxicology, Non-Clinical Drug Development, Pharmacology, Investigational New Drug (IND) Application, Investigator's Brochure (IB) and New Drug Application (NDA), and Management of Clinical Studies.
Keywords: Drug Approval, Clinical Research, Investigational New Drug (IND), New Drug Application (NDA), Biostatistics

Published

February 5, 2025

Categories

How to Cite

Patil, P. R. ., Mali, S. S. ., Patil, R. R. ., & Davare, D. R. . (2025). Regulatory affairs/ regulatory requirements for drug approval. In V. S. Joshi, S. S. . Mali, D. A. . Bhagwat, & P. V. . Chavan (Eds.), Technology and Quality in Industrial Pharmacy: Theory and Practice in Pharmaceutical Sciences (pp. 59-97). Deep Science Publishing. https://doi.org/10.70593/978-93-49307-31-5_3